The ANKK1 Kinase Gene and Psychiatric Disorders

  • Guillermo Ponce
  • Rocío Pérez-González
  • María Aragüés
  • Tomás Palomo
  • Roberto Rodríguez-Jiménez
  • Miguel Angel Jiménez-Arriero
  • Janet Hoenicka


The TaqIA single nucleotide polymorphism (SNP, rs1800497), which is located in the gene that codes for the putative kinase ANKK1 (ANKK1) near the termination codon of the D2 dopamine receptor gene (DRD2; chromosome 11q22–q23), is the most studied genetic variation in a broad range of psychiatric disorders and personality traits. A large number of individual genetic association studies have found that the TaqIA SNP is linked to alcoholism and antisocial traits. In addition, it has also been related to other conditions such as schizophrenia, eating disorders, and some behavioral childhood disorders. The TaqIA A1 allele is mainly associated with addictions, antisocial disorders, eating disorders, and attention-deficit/hyperactivity disorders, while the A2 allele occurs more frequently in schizophrenic and obsessive-compulsive patients. Current data show that the TaqIA polymorphism may be a marker of both DRD2 and ANKK1 genetic variants. ANKK1 would belong to a family of kinases involved in signal transduction. This raises the question of whether signaling players intervene in the pathophysiology of psychiatric disorders. Basic research on the ANKK1 protein and its putative interaction with the D2 dopamine receptor could shed light on this issue.


ANKK1 DRD2 Polymorphism TaqIA Dopamine Addictions Schizophrenia 


  1. Arinami T, Itokawa M, Komiyama T, Mitsushio H, Mori H, Mifune H, Hamaguchi H, Toru M (1993) Association between severity of alcoholism and the A1 allele of the dopamine D2 receptor gene TaqI A RFLP in Japanese. Biol Psychiatry 33:108–114PubMedCrossRefGoogle Scholar
  2. Audrain-McGovern J, Lerman C, Wileyto EP, Rodriguez D, Shields PG (2004) Interacting effects of genetic predisposition and depression on adolescent smoking progression. Am J Psychiatry 161(7):1224–1230PubMedCrossRefGoogle Scholar
  3. Blair RJ (2003) Neurobiological basis of psychopathy. Br J Psychiatry 182:5–7PubMedCrossRefGoogle Scholar
  4. Blum K, Noble EP, Sheridan PJ, Montgomery A, Ritchie T, Jagadeeswaran P, Nogami H, Briggs AH, Cohn JB (1990) Allelic association of human dopamine D2 receptor gene in alcoholism. Jama 263:2055–2060PubMedCrossRefGoogle Scholar
  5. Blum K, Noble EP, Sheridan PJ, Finley O, Montgomery A, Ritchie T, Ozkaragoz T, Fitch RJ, Sadlack F, Sheffield D et al (1991) Association of the A1 allele of the D2 dopamine receptor gene with severe alcoholism. Alcohol 8:409–416PubMedCrossRefGoogle Scholar
  6. Blum K, Braverman ER, Dinardo MJ, Wood RC, Sheridan PJ (1994) Prolonged P300 latency in a neuropsychiatric population with the D2 dopamine receptor A1 allele. Pharmacogenetics 4:313–322PubMedCrossRefGoogle Scholar
  7. Blum K, Braverman ER, Wood RC, Gill J, Li C, Chen TJ, Taub M, Montgomery AR, Sheridan PJ, Cull JG (1996) Increased prevalence of the Taq I A1 allele of the dopamine receptor gene (DRD2) in obesity with comorbid substance use disorder: a preliminary report. Pharmacogenetics 6:297–305PubMedCrossRefGoogle Scholar
  8. Bolos AM, Dean M, Lucas-Derse S, Ramsburg M, Brown GL, Goldman D (1990) Population and pedigree studies reveal a lack of association between the dopamine D2 receptor gene and alcoholism. Jama 264:3156–3160PubMedCrossRefGoogle Scholar
  9. Chen CH, Chien SH, Hwu HG (1996) Lack of association between TaqI A1 allele of dopamine D2 receptor gene and alcohol-use disorders in atayal natives of Taiwan. Am J Med Genet 67:488–490PubMedCrossRefGoogle Scholar
  10. Chen WJ, Lu ML, Hsu YP, Chen CC, Yu JM, Cheng AT (1997) Dopamine D2 receptor gene and alcoholism among four aboriginal groups and Han in Taiwan. Am J Med Genet 74:129–136PubMedCrossRefGoogle Scholar
  11. Chen WJ, Chen CH, Huang J, Hsu YP, Seow SV, Chen CC, Cheng AT (2001) Genetic polymorphisms of the promoter region of dopamine D2 receptor and dopamine transporter genes and alcoholism among four aboriginal groups and Han Chinese in Taiwan. Psychiatr Genet 11:187–195PubMedCrossRefGoogle Scholar
  12. Chen CK, Hu X, Lin SK, Sham PC, Loh el W, Li T, Murray RM, Ball DM (2004) Association analysis of dopamine D2-like receptor genes and methamphetamine abuse. Psychiatr Genet 14:223–226PubMedCrossRefGoogle Scholar
  13. Comings DE, Comings BG, Muhleman D, Dietz G, Shahbahrami B, Tast D, Knell E, Kocsis P, Baumgarten R, Kovacs BW et al (1991) The dopamine D2 receptor locus as a modifying gene in neuropsychiatric disorders. Jama 266:1793–1800PubMedCrossRefGoogle Scholar
  14. Comings DE, Rosenthal RJ, Lesieur HR, Rugle LJ, Muhleman D, Chiu C, Dietz G, Gade R (1996) A study of the dopamine D2 receptor gene in pathological gambling. Pharmacogenetics 6:223–234PubMedCrossRefGoogle Scholar
  15. Connor JP, Young RM, Lawford BR, Saunders JB, Ritchie TL, Noble EP (2007) Heavy nicotine and alcohol use in alcohol dependence is associated with D2 dopamine receptor (DRD2) polymorphism. Addict Behav 32(2):310–319PubMedCrossRefGoogle Scholar
  16. Costa-Mallen P, Costa LG, Smith-Weller T, Franklin GM, Swanson PD, Checkoway H (2000) Genetic polymorphism of dopamine D2 receptors in Parkinson’s disease and interactions with cigarette smoking and MAO-B intron 13 polymorphism. J Neurol Neurosurg Psychiatry 69:535–537PubMedCrossRefGoogle Scholar
  17. Cruz C, Camarena B, Mejia JM, Paez F, Eroza V, Ramon De La Fuente J, Kershenobich D, Nicolini H (1995) The dopamine D2 receptor gene TaqI A1 polymorphism and alcoholism in a Mexican population. Arch Med Res 26:421–426PubMedGoogle Scholar
  18. David SP, Niaura R, Papandonatos GD, Shadel WG, Burkholder GJ, Britt DM, Day A, Stumpff J, Hutchison K, Murphy M, Johnstone E, Griffiths SE, Walton RT (2003) Does the DRD2-Taq1 A polymorphism influence treatment response to bupropion hydrochloride for reduction of the nicotine withdrawal syndrome? Nicotine Tob Res 5(6):935–942PubMedCrossRefGoogle Scholar
  19. Davis C, Levitan RD, Kaplan AS, Carter J, Reid C, Curtis C, Patte K, Hwang R, Kennedy JL (2008) Reward sensitivity and the D2 dopamine receptor gene: A case-control study of binge eating disorder. Prog Neuropsychopharmacol Biol Psychiatry 32(3):620–628PubMedCrossRefGoogle Scholar
  20. Denys D, Van Nieuwerburgh F, Deforce D, Westenberg H (2006) Association between the dopamine D2 receptor TaqI A2 allele and low activity COMT allele with obsessive-compulsive disorder in males. Eur Neuropsychopharmacol 16:446–450PubMedCrossRefGoogle Scholar
  21. Di Chiara G, Imperato A (1998) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci U S A 85:5274–5278CrossRefGoogle Scholar
  22. Dick DM, Wang JC, Plunkett J, Aliev F, Hinrichs A, Bertelsen S, Budde JP, Goldstein EL, Kaplan D, Edenberg HJ, Nurnberger J Jr, Hesselbrock V, Schuckit M, Kuperman S, Tischfield J, Porjesz B, Begleiter H, Bierut LJ, Goate A (2007) Family-based association analyses of alcohol dependence phenotypes across DRD2 and neighboring gene ANKK1. Alcohol Clin Exp Res 31(10):1645–1653PubMedCrossRefGoogle Scholar
  23. Drtilkova I, Sery O, Theiner P, Uhrova A, Zackova M, Balastikova B, Znojil V (2008) Clinical and molecular-genetic markers of ADHD in children. Neuro Endocrinol Lett 29:320–327PubMedGoogle Scholar
  24. Duan J, Wainwright MS, Comeron JM, Saitou N, Sanders AR, Gelernter J, Gejman PV (2003) Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. Hum Mol Genet 12(3):205–216PubMedCrossRefGoogle Scholar
  25. Dubertret C, Gorwood P, Gouya L, Deybach JC, Ades J (2001) Association and excess of transmission of a DRD2 haplotype in a sample of French schizophrenic patients. Schizophr Res 49:203–212PubMedCrossRefGoogle Scholar
  26. Dubertret C, Gouya L, Hanoun N, Deybach JC, Ades J, Hamon M, Gorwood P (2004) The 3′ region of the DRD2 gene is involved in genetic susceptibility to schizophrenia. Schizophr Res 67:75–85PubMedCrossRefGoogle Scholar
  27. Edenberg HJ, Foroud T, Koller DL, Goate A, Rice J, Van Eerdewegh P, Reich T, Cloninger CR, Nurnberger JI Jr, Kowalczuk M, Wu B, Li TK, Conneally PM, Tischfield JA, Wu W, Shears S, Crowe R, Hesselbrock V, Schuckit M, Porjesz B, Begleiter H (1998) A family-based analysis of the association of the dopamine D2 receptor (DRD2) with alcoholism. Alcohol Clin Exp Res 22:505–512PubMedGoogle Scholar
  28. Epstein LH, Temple JL, Neaderhiser BJ, Salis RJ, Erbe RW, Leddy JJ (2007) Food reinforcement, the dopamine D2 receptor genotype, and energy intake in obese and nonobese humans. Behav Neurosci 121:877–886PubMedCrossRefGoogle Scholar
  29. Foley PF, Loh EW, Innes DJ, Williams SM, Tannenberg AE, Harper CG, Dodd PR (2004) Association studies of neurotransmitter gene polymorphisms in alcoholic Caucasians. Ann N Y Acad Sci 1025:39–46PubMedCrossRefGoogle Scholar
  30. Gelernter J, Kranzler H (1999) D2 dopamine receptor gene (DRD2) allele and haplotype frequencies in alcohol dependent and control subjects: no association with phenotype or severity of phenotype. Neuropsychopharmacology 20:640–649PubMedCrossRefGoogle Scholar
  31. Gelernter J, O’Malley S, Risch N, Kranzler HR, Krystal J, Merikangas K, Kennedy JL, Kidd KK (1991) No association between an allele at the D2 dopamine receptor gene (DRD2) and alcoholism. Jama 266:1801–1807PubMedCrossRefGoogle Scholar
  32. Gelernter J, Pauls DL, Leckman J, Kidd KK, Kurlan R (1994) D2 dopamine receptor alleles do not influence severity of Tourette’s syndrome. Results from four large kindreds. Arch Neurol 51:397–400PubMedGoogle Scholar
  33. Gelernter J, Yu Y, Weiss R, Brady K, Panhuysen C, Yang BZ, Kranzler HR, Farrer L (2006) Haplotype spanning TTC12 and ANKK1, flanked by the DRD2 and NCAM1 loci, is strongly associated to nicotine dependence in two distinct American populations. Hum Mol Genet 15(24):3498–3507PubMedCrossRefGoogle Scholar
  34. Gilbert D, McClernon J, Rabinovich N, Sugai C, Plath L, Asgaard G, Zuo Y, Huggenvik J, Botros N (2004) Effects of quitting smoking on EEG activation and attention last for more than 31 days and are more severe with stress, dependence, DRD2 A1 allele, and depressive traits. Nicotine Tob Res 6(2):249–267PubMedCrossRefGoogle Scholar
  35. Goldman D, Urbanek M, Guenther D, Robin R, Long JC (1997) Linkage and association of a functional DRD2 variant [Ser311Cys] and DRD2 markers to alcoholism, substance abuse and schizophrenia in Southwestern American Indians. Am J Med Genet 74:386–394PubMedCrossRefGoogle Scholar
  36. Golimbet VE, Aksenova MG, Abramova LI, Kaleda VG, Orlova VA, Braga EA, Nosikov VV, Trubnikov VI (1998) Association of allele polymorphism of dopamine d2 receptors with schizophrenic and affective disorders. Zh Nevrol Psikhiatr Im S S Korsakova 98:32–35PubMedGoogle Scholar
  37. Golimbet V, Aksenova M, Nosikov V, Orlova V, Kaleda V (2003) Analysis of the linkage of the Taq1A and Taq1B loci of the dopamine D2 receptor gene with schizophrenia in patients and their siblings. Neurosci Behav Physiol 33:223–225PubMedCrossRefGoogle Scholar
  38. Grevle L, Guzey C, Hadidi H, Brennersted R, Idle JR, Aasly J (2000) Allelic association between the DRD2 TaqI A polymorphism and Parkinson’s disease. Mov Disord 15:1070–1074PubMedCrossRefGoogle Scholar
  39. Hietala J, Pohjalainen T, Heikkila-Kallio U, West C, Salaspuro M, Syvalahti E (1997) Allelic association between D2 but not D1 dopamine receptor gene and alcoholism in Finland. Psychiatr Genet 7:19–25PubMedCrossRefGoogle Scholar
  40. Hill SY, Locke J, Zezza N, Kaplan B, Neiswanger K, Steinhauer SR, Wipprecht G, Xu J (1998) Genetic association between reduced P300 amplitude and the DRD2 dopamine receptor A1 allele in children at high risk for alcoholism. Biol Psychiatry 43:40–51PubMedCrossRefGoogle Scholar
  41. Hirvonen M, Laakso A, Någren K, Rinne JO, Pohjalainen T, Hietala J (2004) C957T polymorphism of the dopamine D2 receptor (DRD2) gene affects striatal DRD2 availability in vivo. Mol Psychiatry 9(12):1060–1061PubMedCrossRefGoogle Scholar
  42. Hirvonen J, van Erp TG, Huttunen J, Aalto S, Någren K, Huttunen M, Lönnqvist J, Kaprio J, Hietala J, Cannon TD (2005) Increased caudate dopamine D2 receptor availability as a genetic marker for schizophrenia. Arch Gen Psychiatry 62(4):371–378PubMedCrossRefGoogle Scholar
  43. Hoenicka J, Ponce G, Jimenez-Arriero MA, Ampuero I, Rodriguez-Jimenez R, Rubio G, Aragues M, Ramos JA, Palomo T (2007) Association in alcoholic patients between psychopathic traits and the additive effect of allelic forms of the CNR1 and FAAH endocannabinoid genes, and the 3′ region of the DRD2 gene. Neurotox Res 11:51–60PubMedCrossRefGoogle Scholar
  44. Huang YS, Lin SK, Wu YY, Chao CC, Chen CK (2003) A family-based association study of attention-deficit hyperactivity disorder and dopamine D2 receptor TaqI A alleles. Chang Gung Med J 26:897–903PubMedGoogle Scholar
  45. Huang W, Payne TJ, Ma JZ, Beuten J, Dupont RT, Inohara N, Li MD (2009) Significant association of ANKK1 and detection of a functional polymorphism with nicotine dependence in an African-American sample. Neuropsychopharmacology 34(2):319–330Google Scholar
  46. Inoue K, Lupski JR (2003) Genetics and genomics of behavioral and psychiatric disorders. Curr Opin Genet Dev 13:303–309PubMedCrossRefGoogle Scholar
  47. Ishiguro H, Arinami T, Saito T, Akazawa S, Enomoto M, Mitushio H, Fujishiro H, Tada K, Akimoto Y, Mifune H, Shioduka S, Hamaguchi H, Toru M, Shibuya H (1998) Association study between the −141C Ins/Del and TaqI A polymorphisms of the dopamine D2 receptor gene and alcoholism. Alcohol Clin Exp Res 22:845–848PubMedGoogle Scholar
  48. Jimenez-Arriero M, Ponce G, Rodriguez-Jimenez RMA, Galvan A, Rubio G, Hoenicka J, Palomo T (2006) TaqI-A polymorphism linked to the DRD2 gene and P300 in alcoholic patients. Eur J Psych 20:45–53Google Scholar
  49. Kono Y, Yoneda H, Sakai T, Nonomura Y, Inayama Y, Koh J, Sakai J, Inada Y, Imamichi H, Asaba H (1997) Association between early-onset alcoholism and the dopamine D2 receptor gene. Am J Med Genet 74:179–182PubMedCrossRefGoogle Scholar
  50. Kumar S, Tamura K, Jakobsen IB, Nei M (2001) MEGA2: molecular evolutionary genetics analysis software. Bioinformatics 17:1244–1245PubMedCrossRefGoogle Scholar
  51. Laakso A, Pohjalainen T, Bergman J, Kajander J, Haaparanta M, Solin O, Syvalahti E, Hietala J (2005) The A1 allele of the human D2 dopamine receptor gene is associated with increased activity of striatal l-amino acid decarboxylase in healthy subjects. Pharmacogenet Genomics 15:387–391PubMedCrossRefGoogle Scholar
  52. Laruelle M (1998) Imaging dopamine transmission in schizophrenia. A review and meta-analysis. Q J Nucl Med 42:211–221PubMedGoogle Scholar
  53. Lawford BR, Young RM, Noble EP, Sargent J, Rowell J, Shadforth S, Zhang X, Ritchie T (2000) The D(2) dopamine receptor A(1) allele and opioid dependence: association with heroin use and response to methadone treatment. Am J Med Genet 96:592–598PubMedCrossRefGoogle Scholar
  54. Lobos EA, Todd RD (1998) Association analysis in an evolutionary context: cladistic analysis of the DRD2 locus to test for association with alcoholism. Am J Med Genet 81:411–419PubMedCrossRefGoogle Scholar
  55. Lu RB, Ko HC, Chang FM, Castiglione CM, Schoolfield G, Pakstis AJ, Kidd JR, Kidd KK (1996) No association between alcoholism and multiple polymorphisms at the dopamine D2 receptor gene (DRD2) in three distinct Taiwanese populations. Biol Psychiatry 39:419–429PubMedCrossRefGoogle Scholar
  56. Magro F, Cunha E, Araujo F, Meireles E, Pereira P, Dinis-Ribeiro M, Veloso FT, Medeiros R, Soares-da-Silva P (2006) Dopamine D2 receptor polymorphisms in inflammatory bowel disease and the refractory response to treatment. Dig Dis Sci 51:2039–2044PubMedCrossRefGoogle Scholar
  57. Meylan E, Tschopp J (2005) The RIP kinases: crucial integrators of cellular stress. Trends Biochem Sci 30:151–159PubMedCrossRefGoogle Scholar
  58. Moldin S (1999) Report of the national institute of mental health’s genetics workgroup: summary of research. Biol Psychiatry 45:573–602CrossRefGoogle Scholar
  59. Morens DM, Grandinetti A, Reed D, White LR, Ross GW (1995) Cigarette smoking and protection from Parkinson’s disease: false association or etiologic clue? Neurology 45:1041–1051PubMedGoogle Scholar
  60. Morton LM, Wang SS, Bergen AW, Chatterjee N, Kvale P, Welch R, Yeager M, Hayes RB, Chanock SJ, Caporaso NE (2006) DRD2 genetic variation in relation to smoking and obesity in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Pharmacogenet Genomics 16(12):901–910PubMedCrossRefGoogle Scholar
  61. Munafo M, Clark T, Johnstone E, Murphy M, Walton R (2004) The genetic basis for smoking behavior: a systematic review and meta-analysis. Nicotine Tob Res 6(4):583–597PubMedCrossRefGoogle Scholar
  62. Munafo MR, Matheson IJ, Flint J (2007) Association of the DRD2 gene Taq1A polymorphism and alcoholism: a meta-analysis of case-control studies and evidence of publication bias. Mol Psychiatry 12:454–461PubMedGoogle Scholar
  63. Neiswanger K, Hill SY, Kaplan BB (1995) Association and linkage studies of the TAQI A1 allele at the dopamine D2 receptor gene in samples of female and male alcoholics. Am J Med Genet 60:267–271PubMedCrossRefGoogle Scholar
  64. Neville MJ, Johnstone EC, Walton RT (2004) Identification and characterization of ANKK1: a novel kinase gene closely linked to DRD2 on chromosome band 11q23.1. Hum Mutat 23:540–545PubMedCrossRefGoogle Scholar
  65. Newman JP, Kosson DS, Patterson CM (1992) Delay of gratification in psychopathic and nonpsychopathic offenders. Abnorm Psychol 101(4):630–636CrossRefGoogle Scholar
  66. Nicolini H, Cruz C, Camarena B, Orozco B, Kennedy JL, King N, Weissbecker K, de la Fuente JR, Sidenberg D (1996) DRD2, DRD3 and 5HT2A receptor genes polymorphisms in obsessive-compulsive disorder. Mol Psychiatry 1:461–465PubMedGoogle Scholar
  67. Nicolini H, Cruz C, Paez F, Camarena B (1998) Dopamine D2 and D4 receptor genes distinguish the clinical presence of tics in obsessive-compulsive disorder. Gac Med Mex 134:521–527PubMedGoogle Scholar
  68. Nisoli E, Brunani A, Borgomainerio E, Tonello C, Dioni L, Briscini L, Redaelli G, Molinari E, Cavagnini F, Carruba MO (2007) D2 dopamine receptor (DRD2) gene Taq1A polymorphism and the eating-related psychological traits in eating disorders (anorexia nervosa and bulimia) and obesity. Eat Weight Disord 12:91–96PubMedGoogle Scholar
  69. Noble EP (1994) Polymorphisms of the D2 dopamine receptor gene and alcoholism and other substance use disorders. Alcohol Alcohol Suppl 2:35–43PubMedGoogle Scholar
  70. Noble EP (2003) D2 dopamine receptor gene in psychiatric and neurologic disorders and its phenotypes. Am J Med Genet B Neuropsychiatr Genet 116:103–125CrossRefGoogle Scholar
  71. Noble EP, Blum K, Ritchie T, Montgomery A, Sheridan PJ (1991) Allelic association of the D2 dopamine receptor gene with receptor-binding characteristics in alcoholism. Arch Gen Psychiatry 48(7):648–654PubMedGoogle Scholar
  72. Noble EP, Blum K, Khalsa ME, Ritchie T, Montgomery A, Wood RC, Fitch RJ, Ozkaragoz T, Sheridan PJ, Anglin MD et al (1993) Allelic association of the D2 dopamine receptor gene with cocaine dependence. Drug Alcohol Depend 33(3):271–285PubMedCrossRefGoogle Scholar
  73. Nothen MM, Hebebrand J, Knapp M, Hebebrand K, Camps A, von Gontard A, Wettke-Schafer R, Lisch S, Cichon S, Poustka F et al (1994) Association analysis of the dopamine D2 receptor gene in Tourette’s syndrome using the haplotype relative risk method. Am J Med Genet 54:249–252PubMedCrossRefGoogle Scholar
  74. Oliveri RL, Annesi G, Zappia M, Civitelli D, De Marco EV, Pasqua AA, Annesi F, Spadafora P, Gambardella A, Nicoletti G, Branca D, Caracciolo M, Aguglia U, Quattrone A (2000) The dopamine D2 receptor gene is a susceptibility locus for Parkinson’s disease. Mov Disord 15:127–131PubMedCrossRefGoogle Scholar
  75. Parsian A, Todd RD, Devor EJ, O’Malley KL, Suarez BK, Reich T, Cloninger CR (1991) Alcoholism and alleles of the human D2 dopamine receptor locus. Studies of association and linkage. Arch Gen Psychiatry 48:655–663PubMedGoogle Scholar
  76. Parsons MJ, Mata I, Beperet M, Iribarren-Iriso F, Arroyo B, Sainz R, Arranz MJ, Kerwin R (2007) A dopamine D2 receptor gene-related polymorphism is associated with schizophrenia in a Spanish population isolate. Psychiatr Genet 17:159–163PubMedCrossRefGoogle Scholar
  77. Perez de los Cobos J, Baiget M, Trujols J, Sinol N, Volpini V, Banuls E, Calafell F, Luquero E, del Rio E, Alvarez E (2007) Allelic and genotypic associations of DRD2 TaqI A polymorphism with heroin dependence in Spanish subjects: a case control study. Behav Brain Funct 3:25PubMedCrossRefGoogle Scholar
  78. Persico AM, Bird G, Gabbay FH, Uhl GR (1996) D2 dopamine receptor gene TaqI A1 and B1 restriction fragment length polymorphisms: enhanced frequencies in psychostimulant-preferring polysubstance abusers. Biol Psychiatry 40:776–784PubMedCrossRefGoogle Scholar
  79. Pohjalainen T, Rinne JO, Nagren K, Lehikoinen P, Anttila K, Syvalahti EK, Hietala J (1998) The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers. Mol Psychiatry 3:256–260PubMedCrossRefGoogle Scholar
  80. Ponce G, Jimenez-Arriero MA, Rubio G, Hoenicka J, Ampuero I, Ramos JA, Palomo T (2003) The A1 allele of the DRD2 gene (TaqI A polymorphisms) is associated with antisocial personality in a sample of alcohol-dependent patients. Eur Psychiatry 18(7):356–360PubMedCrossRefGoogle Scholar
  81. Ponce G, Hoenicka J, Jimenez-Arriero MA, Rodriguez-Jimenez R, Aragues M, Martin-Sune N, Huertas E, Palomo T (2008) DRD2 and ANKK1 genotype in alcohol-dependent patients with psychopathic traits: association and interaction study. Br J Psychiatry 193:121–125PubMedCrossRefGoogle Scholar
  82. Ratsma JE, van der Stelt O, Schoffelmeer AN, Westerveld A, Gunning WB (2001) P3 event-related potential, dopamine D2 receptor A1 allele, and sensation-seeking in adult children of alcoholics. Alcohol Clin Exp Res 25:960–967PubMedCrossRefGoogle Scholar
  83. Ritchie T, Noble EP (2003) Association of seven polymorphisms of the D2 dopamine receptor gene with brain receptor-binding characteristics. Neurochem Res 28:73–82PubMedCrossRefGoogle Scholar
  84. Rodríguez-Jiménez R, Aragüés M, Hoenicka J, Martinez-Gras I, Ponce G, Cubillo A, Bagney A, Jiménez-Arriero M, Rubio G, Palomo T, Psychosis and addictions research group P (2005) The TaqIA polymorphism, linked to the DRD2 gene, is associated with substance use disorders in schizophrenic patients (dual diagnosis). Implications of comorbidity for etiology and treatment of neuropsychiatric disorders—Mazagón (Huelva), October 19–23 2005Google Scholar
  85. Rowe DC, Van den Oord EJ, Stever C, Giedinghagen LN, Gard JM, Cleveland HH, Gilson M, Terris ST, Mohr JH, Sherman S, Abramowitz A, Waldman ID (1999) The DRD2 TaqI polymorphism and symptoms of attention deficit hyperactivity disorder. Mol Psychiatry 4:580–586PubMedCrossRefGoogle Scholar
  86. Sander T, Harms H, Podschus J, Finckh U, Nickel B, Rolfs A, Rommelspacher H, Schmidt LG (1995) Dopamine D1, D2 and D3 receptor genes in alcohol dependence. Psychiatr Genet 5:171–176PubMedCrossRefGoogle Scholar
  87. Sander T, Ladehoff M, Samochowiec J, Finckh U, Rommelspacher H, Schmidt LG (1999) Lack of an allelic association between polymorphisms of the dopamine D2 receptor gene and alcohol dependence in the German population. Alcohol Clin Exp Res 23:578–581PubMedGoogle Scholar
  88. Seeman P, Bzowej NH, Guan HC, Bergeron C, Reynolds GP, Bird ED, Riederer P, Jellinger K, Tourtellotte WW (1987) Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer’s, Parkinson’s, and Huntington’s diseases. Neuropsychopharmacology 1:5–15PubMedCrossRefGoogle Scholar
  89. Sery O, Drtilkova I, Theiner P, Pitelova R, Staif R, Znojil V, Lochman J, Didden W (2006) Polymorphism of DRD2 gene and ADHD. Neuro Endocrinol Lett 27:236–240PubMedGoogle Scholar
  90. Smith L, Watson M, Gates S, Ball D, Foxcroft D (2008) Meta-analysis of the association of the Taq1A polymorphism with the risk of alcohol dependency: a HuGE gene-disease association review. Am J Epidemiol 167:125–138PubMedCrossRefGoogle Scholar
  91. Stice E, Spoor S, Bohon C, Small DM (2008) Relation between obesity and blunted striatal response to food is moderated by TaqIA A1 allele. Science 322:449–452PubMedCrossRefGoogle Scholar
  92. Suarez BK, Parsian A, Hampe CL, Todd RD, Reich T, Cloninger CR (1994) Linkage disequilibria at the D2 dopamine receptor locus (DRD2) in alcoholics and controls. Genomics 19:12–20PubMedCrossRefGoogle Scholar
  93. Thompson J, Thomas N, Singleton A, Piggott M, Lloyd S, Perry EK, Morris CM, Perry RH, Ferrier IN, Court JA (1997) D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics 7:479–484PubMedCrossRefGoogle Scholar
  94. Turner E, Ewing J, Shilling P, Smith TL, Irwin M, Schuckit M, Kelsoe JR (1992) Lack of association between an RFLP near the D2 dopamine receptor gene and severe alcoholism. Biol Psychiatry 31:285–290PubMedCrossRefGoogle Scholar
  95. Vijayan NN, Bhaskaran S, Koshy LV, Natarajan C, Srinivas L, Nair CM, Allencherry PM, Banerjee M (2007) Association of dopamine receptor polymorphisms with schizophrenia and antipsychotic response in a South Indian population. Behav Brain Funct 3:34PubMedCrossRefGoogle Scholar
  96. Waldman ID, Robinson BF, Rhee SH (1999) A logistic regression extension of the transmission disequilibrium test for continuous traits: application to linkage disequilibrium between alcoholism and the candidate genes DRD2 and ADH3. Genet Epidemiol 17(Suppl 1):S379–S384PubMedGoogle Scholar
  97. Wong AH, Gottesman II, Petronis A (2005) Phenotypic differences in genetically identical organisms: the epigenetic perspective. Hum Mol Genet 14 Spec No 1:R11-18Google Scholar
  98. Yang BZ, Kranzler HR, Zhao H, Gruen JR, Luo X, Gelernter J (2007) Association of haplotypic variants in DRD2, ANKK1, TTC12 and NCAM1 to alcohol dependence in independent case control and family samples. Hum Mol Genet 16:2844–2853PubMedCrossRefGoogle Scholar
  99. Yang BZ, Kranzler HR, Zhao H, Gruen JR, Luo X, Gelernter J (2008) Haplotypic variants in DRD2, ANKK1, TTC12, and NCAM1 are associated with comorbid alcohol and drug dependence. Alcohol Clin Exp Res 32(12):2117–2127Google Scholar
  100. Zhang Y, Bertolino A, Fazio L, Blasi G, Rampino A, Romano R, Lee ML, Xiao T, Papp A, Wang D, Sadee W (2007) Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory. Proc Natl Acad Sci U S A 104:20552–20557PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Guillermo Ponce
    • 1
    • 2
  • Rocío Pérez-González
    • 1
  • María Aragüés
    • 1
    • 2
  • Tomás Palomo
    • 1
    • 2
  • Roberto Rodríguez-Jiménez
    • 1
    • 2
  • Miguel Angel Jiménez-Arriero
    • 1
    • 2
  • Janet Hoenicka
    • 1
    • 2
  1. 1.Unidad de Alcoholismo y Patología Dual, Servicio de PsiquiatríaHospital UniversitarioMadridSpain
  2. 2.CIBER de Salud Mental (CIBERSAM)Instituto de Salud Carlos IIIMadridSpain

Personalised recommendations